These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37629753)

  • 1. Radiation Therapy Changed the Second Malignancy Pattern in Rectal Cancer Survivors.
    Ye X; Tan Y; Ma R; Lou P; Yuan Y
    Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629753
    [No Abstract]   [Full Text] [Related]  

  • 2. Secondary Cancers After Radiation Therapy for Primary Prostate or Rectal Cancer.
    Lee YC; Hsieh CC; Li CY; Chuang JP; Lee JC
    World J Surg; 2016 Apr; 40(4):895-905. PubMed ID: 26711638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary malignancies after rectal cancer resection with and without radiation therapy: A propensity-adjusted, population-based SEER analysis.
    Warschkow R; Güller U; Cerny T; Schmied BM; Plasswilm L; Putora PM
    Radiother Oncol; 2017 Apr; 123(1):139-146. PubMed ID: 28285840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of second cancers according to radiation therapy technique and modality in prostate cancer survivors.
    Berrington de Gonzalez A; Wong J; Kleinerman R; Kim C; Morton L; Bekelman JE
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):295-302. PubMed ID: 25636756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
    Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL
    Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Incidence Characteristics of Second Primary Malignancy after Diagnosis of Primary Colon and Rectal Cancer: A Population Based Study.
    Guan X; Jin Y; Chen Y; Jiang Z; Liu Z; Zhao Z; Yan P; Wang G; Wang X
    PLoS One; 2015; 10(11):e0143067. PubMed ID: 26571301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of second malignancies in prostate cancer patients treated with low-dose-rate brachytherapy and radical prostatectomy.
    Hamilton SN; Tyldesley S; Hamm J; Jiang WN; Keyes M; Pickles T; Lapointe V; Kahnamelli A; McKenzie M; Miller S; Morris WJ
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):934-41. PubMed ID: 25240272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of colorectal cancer and prostate cancer and impact of radiation therapy.
    Huo D; Hetzel JT; Roy H; Rubin DT
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):1979-85. PubMed ID: 19531678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bladder carcinoma and other second malignancies after radiotherapy for prostate carcinoma.
    Neugut AI; Ahsan H; Robinson E; Ennis RD
    Cancer; 1997 Apr; 79(8):1600-4. PubMed ID: 9118045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
    Wu GX; Nelson RA; Kim JY; Raz DJ
    Clin Lung Cancer; 2017 Sep; 18(5):543-550.e3. PubMed ID: 28412093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of second malignancies among survivors of pediatric thyroid cancer.
    Adly MH; Sobhy M; Rezk MA; Ishak M; Afifi MA; Shafie AE; Ali MA; Zekri W; Alfaar AS; Rashed WM
    Int J Clin Oncol; 2018 Aug; 23(4):625-633. PubMed ID: 29492793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of second primary cancer after treatment for esophageal cancer: a pooled analysis of nine cancer registries.
    Zhu G; Chen Y; Zhu Z; Lu L; Bi X; Deng Q; Chen X; Su H; Liu Y; Guo H; Zheng T; Yu H; Zhang Y
    Dis Esophagus; 2012 Aug; 25(6):505-11. PubMed ID: 22067063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of second primary malignancies associated with radiotherapy in prostate cancer patients: competing risk analysis.
    Wu Y; Li Y; Han C; Chong Y; Kang K; Liu Z; Zhang F
    Future Oncol; 2022 Feb; 18(4):445-455. PubMed ID: 35018785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Radiotherapy for Rectal Cancer and Second Gynecological Malignant Neoplasms.
    Guan X; Wei R; Yang R; Lu Z; Liu E; Zhao Z; Chen H; Yang M; Liu Z; Jiang Z; Wang X
    JAMA Netw Open; 2021 Jan; 4(1):e2031661. PubMed ID: 33416884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second primary malignancy risk after radiotherapy in rectal cancer survivors.
    Wang TH; Liu CJ; Chao TF; Chen TJ; Hu YW
    World J Gastroenterol; 2018 Oct; 24(40):4586-4595. PubMed ID: 30386108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk of second malignancy in men with prostate cancer treated with or without radiation in British Columbia, 1984-2000.
    Pickles T; Phillips N
    Radiother Oncol; 2002 Dec; 65(3):145-51. PubMed ID: 12464442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of second primary tumors in men diagnosed with prostate cancer: a population-based cohort study.
    Davis EJ; Beebe-Dimmer JL; Yee CL; Cooney KA
    Cancer; 2014 Sep; 120(17):2735-41. PubMed ID: 24842808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coupling of prostate and thyroid cancer diagnoses in the United States.
    Tomaszewski JJ; Uzzo RG; Egleston B; Corcoran AT; Mehrazin R; Geynisman DM; Ridge JA; Veloski C; Kocher N; Smaldone MC; Kutikov A
    Ann Surg Oncol; 2015 Mar; 22(3):1043-9. PubMed ID: 25205302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and risk outcomes of second primary malignancy of patients with post-operative colorectal cancer.
    Yang J; Wu F; An H; Gan H
    Int J Colorectal Dis; 2023 Mar; 38(1):88. PubMed ID: 36995483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subsequent malignant neoplasms in the Childhood Cancer Survivor Study: Occurrence of cancer types in which human papillomavirus is an established etiologic risk factor.
    Henderson TO; Fowler BW; Hamann HA; Nathan PC; Whitton J; Leisenring WM; Oeffinger KC; Neglia JP; Turcotte LM; Arnold MA; Conces MR; Howell RM; Robison LL; Armstrong GT; Alexander KA
    Cancer; 2022 Jan; 128(2):373-382. PubMed ID: 34606625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.